A phase 2 trial of flavopiridol (Alvocidib) and cisplatin in platin-resistant ovarian and primary peritoneal carcinoma: MC0261

Keith C. Bible, Prema P. Peethambaram, Ann L. Oberg, William Maples, David L. Groteluschen, Matthew Boente, Jill K. Burton, Leigh C. Gomez Dahl, Jennifer D. Tibodeau, Crescent R. Isham, Jacie L. Maguire, Viji Shridhar, Andrea K. Kukla, Kalli J. Voll, Mathew J. Mauer, Alexander D. Colevas, John Wright, L. Austin Doyle, Charles Erlichman

Research output: Contribution to journalArticlepeer-review

48 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 2 trial of flavopiridol (Alvocidib) and cisplatin in platin-resistant ovarian and primary peritoneal carcinoma: MC0261'. Together they form a unique fingerprint.

Medicine & Life Sciences